Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells

INTRODUCTION: Monoclonal antibodies and targeted therapies against HER2+ breast cancer has improved overall and disease-free survival in patients; however, encountering drug resistance causes recurrence, necessitating the development of newer HER2-targeted medications. A curcumin analog PGB-0-ol sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermawan, Adam, Wulandari, Febri, Yudi Utomo, Rohmad, Asmah Susidarti, Ratna, Kirihata, Mitsunori, Meiyanto, Edy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652209/
https://www.ncbi.nlm.nih.gov/pubmed/38028209
http://dx.doi.org/10.1016/j.jsps.2023.101847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652209/
https://www.ncbi.nlm.nih.gov/pubmed/38028209
http://dx.doi.org/10.1016/j.jsps.2023.101847

Ejemplares similares